loader
Please Wait
Applying Filters...

Looking for Lubricants & Glidants? Find Lubricants & Glidants Agents used in Montelukast Sodium to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 1,133Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Minakem

02 2SPI Pharma

03 2Jai Radhe Sales

04 2Chynops Pharma

05 4Gangwal Healthcare

06 9Nanjing Well Pharmaceutical

07 2Aeon Procare

08 2Alcedo Pharmachem

09 4Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 2BASF

11 10Microlex e.U

12 2NEWEDGE Overseas

13 4Pharmatrans-Sanaq

14 2Pluviaendo

15 3Prachin Chemical

16 2Shanghai Shenmei Pharmaceutical Technology Co., Ltd

17 2Sigachi Industries

18 1Vasa Pharmachem

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Ingredient(s) : Sodium Stearyl Fumarate

Dosage Form : Capsule, Tablet

Category : Lubricants & Glidants

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.

Dosage Form : Capsule, Tablet

Category : Lubricants & Glidants

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

06

arrow
SupplySide West 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Oral, Topical

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

08

arrow
SupplySide West 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Oral, Topical

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

11

arrow
SupplySide West 2024
Not Confirmed

12

arrow
SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed

Brand Name : Microlex® MS-101

Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-101

Applications : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

13

arrow
SupplySide West 2024
Not Confirmed

14

arrow
SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
blank

15

arrow
SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
blank

17

arrow
SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed

Brand Name : Microlex® MS-102

Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-102

Applications : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow
blank

18

arrow
SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
blank

19

arrow
SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed

Brand Name : Microlex® MS-103

Excipient Details : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-103

Applications : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

20

arrow
SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
blank

21

arrow
SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
blank

24

arrow
SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
blank

26

arrow
SupplySide West 2024
Not Confirmed

28

arrow
SupplySide West 2024
Not Confirmed

29

arrow
SupplySide West 2024
Not Confirmed